Abatacept is a selective T cell co-stimulation modulator that was first approved by the Italian Medicines Agency and reimbursed by the Italian National Health Service when used to treat active rheumatoid arthritis "not sufficiently responsive to other disease-modifying anti-rheumatic drugs (DMARDs) including at least one TNF inhibitor", and is now also approved as a first line biological agent. The aim of this review is to summarise the safety data collected in clinical trials and observational studies.

Long-term safety of abatacept in patients with rheumatoid arthritis / F. Atzeni, P. Sarzi-Puttini, A. Mutti, S. Bugatti, L. Cavagna, R. Caporali. - In: AUTOIMMUNITY REVIEWS. - ISSN 1568-9972. - 12:12(2013 Dec), pp. 1115-1117. [10.1016/j.autrev.2013.06.011]

Long-term safety of abatacept in patients with rheumatoid arthritis

P. Sarzi-Puttini;A. Mutti;R. Caporali
2013-12

Abstract

Abatacept is a selective T cell co-stimulation modulator that was first approved by the Italian Medicines Agency and reimbursed by the Italian National Health Service when used to treat active rheumatoid arthritis "not sufficiently responsive to other disease-modifying anti-rheumatic drugs (DMARDs) including at least one TNF inhibitor", and is now also approved as a first line biological agent. The aim of this review is to summarise the safety data collected in clinical trials and observational studies.
Abatacept; Rheumatoid arthritis; Safety
Settore MED/16 - Reumatologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1568997213001158-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 134.22 kB
Formato Adobe PDF
134.22 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/643255
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 29
social impact